These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31147207)

  • 1. Pharmacy practice in the domain of assisted dying: A mapping review of the literature.
    Woods P; Schindel TJ; King MA; Mey A
    Res Social Adm Pharm; 2020 Mar; 16(3):267-276. PubMed ID: 31147207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "If I were to do this, how would I experience it?" Developing a theoretical framework for exploring pharmacists' practice in the domain of assisted dying.
    Woods P; King MA; Mey A; Schindel TJ
    Res Social Adm Pharm; 2021 Apr; 17(4):685-693. PubMed ID: 32616431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' involvement in and attitudes toward pharmacy practice research: A systematic review of the literature.
    Awaisu A; Alsalimy N
    Res Social Adm Pharm; 2015; 11(6):725-48. PubMed ID: 25698363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital Pharmacists' Experiences with Medical Assistance in Dying: A Qualitative Study.
    Schindel TJ; Woods P; Mey A; King MA; Gray M; Navarrete J
    Can J Hosp Pharm; 2022; 75(4):294-301. PubMed ID: 36246437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Ethical Pharmacy Practice in Jordan.
    Fino LB; Basheti IA; Chaar BB
    Sci Eng Ethics; 2020 Oct; 26(5):2809-2834. PubMed ID: 32533448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' Attitudes towards Medically Assisted Dying.
    Wong LS; Scahill SL; Barton E; Van der Werf B; Boey J; Ram SS
    Pharmacy (Basel); 2024 Feb; 12(2):. PubMed ID: 38391008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' communication with Spanish-speaking patients: a review of the literature to establish an agenda for future research.
    Dilworth TJ; ; Mott D; Young H
    Res Social Adm Pharm; 2009 Jun; 5(2):108-20. PubMed ID: 19524859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
    Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
    J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness and impact on performance of pharmacy-related competency development frameworks: A systematic review and meta-analysis.
    Udoh A; Bruno-Tomé A; Ernawati DK; Galbraith K; Bates I
    Res Social Adm Pharm; 2021 Oct; 17(10):1685-1696. PubMed ID: 33608245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian pharmacists' perspectives on physician-assisted suicide (PAS): thematic analysis of semistructured interviews.
    Isaac S; McLachlan A; Chaar B
    BMJ Open; 2019 Oct; 9(10):e028868. PubMed ID: 31666261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring pharmacy ethics in developing countries: a scoping review.
    Fino LB; Basheti IA; Saini B; Moles R; Chaar BB
    Int J Clin Pharm; 2020 Apr; 42(2):418-435. PubMed ID: 32277402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical assistance in dying: Examining Canadian pharmacy perspectives using a mixed-methods approach.
    Verweel L; Rosenberg-Yunger ZRS; Movahedi T; Malek AH
    Can Pharm J (Ott); 2018; 151(2):121-132. PubMed ID: 29531630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.
    Hindi AMK; Jacobs S; Schafheutle EI
    Health Soc Care Community; 2019 May; 27(3):565-598. PubMed ID: 30047617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and attributes of pharmacists in relation to practice change - A scoping review and discussion.
    Luetsch K
    Res Social Adm Pharm; 2017; 13(3):440-455.e11. PubMed ID: 27459951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
    Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
    BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aid-in-dying practice in Europe and the United States: Legal and ethical perspectives for pharmacy.
    Varadarajan R; Freeman RA; Parmar JR
    Res Social Adm Pharm; 2016; 12(6):1016-1025. PubMed ID: 26711140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping review of the methods and processes used by regulatory bodies to determine pharmacists' readiness for practice.
    Ni Sheachnasaigh E; Cadogan C; Strawbridge J; Sahm LJ; Ryan C
    Res Social Adm Pharm; 2022 Dec; 18(12):4028-4037. PubMed ID: 35835686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role theory: literature review and implications for patient-pharmacist interactions.
    Guirguis LM; Chewning BA
    Res Social Adm Pharm; 2005 Dec; 1(4):483-507. PubMed ID: 17138492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacy teams' experiences of general practice-based pharmacists: an exploratory qualitative study.
    Karampatakis GD; Patel N; Stretch G; Ryan K
    BMC Health Serv Res; 2020 May; 20(1):431. PubMed ID: 32423485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.